Scarica l'app Stockscreener
0.746
4.80%
-0.0376
Dopo l'orario di chiusura:
.77
0.024
+3.22%
Citius Oncology Inc Azioni (CTOR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
10.41%
1.4938
|
1.6673 | 3.9441 | - | - |
| Cost Of Revenue |
49.55%
0.4918
|
0.3289 | 0.7892 | - | - |
| Gross Profit |
25.14%
1.0019
|
1.3384 | 3.1549 | - | - |
| Operating Expenses |
67.55%
9.7188
|
29.95 | 8.4072 | 4.7115 | 4.945 |
| Operating Income/Loss |
69.54%
-8.7168
|
-28.61 | -5.2523 | -4.7115 | -4.945 |
| Nonoperating Income/Loss |
117.73%
-0.3144
|
1.7727 | -0.0176 | - | - |
| Income/Loss From Continuing Operations Before Tax |
66.35%
-9.0312
|
-26.84 | -5.2698 | -4.7324 | -5.1057 |
| Income Tax Expense/Benefit, Deferred |
53.57%
-0.1073
|
-0.2312 | 0.2642 | 0.2642 | 0.2642 |
| Income Tax Expense/Benefit |
53.57%
-0.1073
|
-0.2312 | 0.2642 | 0.2642 | 0.2642 |
| Net Income/Loss |
66.46%
-8.9238
|
-26.61 | -5.5341 | -4.9967 | -5.37 |
| Basic Average Shares |
7.86%
107.89
|
100.03 | 87.46 | 1.7156 | 71.55 |
| Diluted Average Shares |
7.86%
107.89
|
100.03 | 87.46 | 1.7156 | 71.55 |
| Basic Earnings Per Share |
70.37%
-0.08
|
-0.27 | -0.06 | -0.06 | -0.08 |
| Diluted Earnings Per Share |
70.37%
-0.08
|
-0.27 | -0.06 | -0.06 | -0.08 |
1.96%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):